The History and Contributions of the Diabetes in Pregnancy Study Group of North America (1997–2015)

Abstract

The Diabetes in Pregnancy Study Group of North America (DPSG-NA) was founded in 1997 in San Antonio, Texas, out of the recognition that the field of maternal–fetal medicine should support and conduct research to address the specialized needs of pregnant women with type 1, type 2, or gestational diabetes mellitus. Since its inception, the DPSG-NA meetings have become a vehicle for the dissemination of data, gathered through collaboration among basic, translational, and clinical researchers and care centers, both in the United States and abroad. Although the meetings cover a range of topics related to diabetes in pregnancy, they have often highlighted a major, timely issue. Utilizing presentations, roundtable discussions, and debates, members of the DPSG-NA discussed the latest research, treatments, and approaches to significantly improve the health and wellbeing of pregnant women with diabetes and their offspring. The following commentary highlights the major contributions of each meeting.

Keywords

diabetes - pregnancy - obesity - diabesity - gestational diabetes mellitus

• References

• 1 Oakley WG. Trans Med Soc Lond 1962; 78: 16
• 2 McElvy SS, Miodovnik M, Rosenn B , et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000; 9 (1) 14-20
• 3 Reece EA, Homko CJ. Prepregnancy care and the prevention of fetal malformations in the pregnancy complicated by diabetes. Clin Obstet Gynecol 2007; 50 (4) 990-997
• 4 Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab 1996; 22 (2) 122-131
• 5 Reece EA, Maulik D. A consensus conference of the Diabetes in Pregnancy Study Group of North America. J Matern Fetal Neonatal Med 2002; 12 (6) 361
• 6 VanDorsten JP, Dodson WC, Espeland MA, Grobman WA , et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013; 29 (1) 1-30
• 7 Langer O, Miodovnik M, Reece EA, Gabbe SG, Rosenn BM, Catalano P. Introduction and summary statement. Prenat Neonatal Med 1998; 3: 514-516
• 8 Gabbe SG. Summation of the second meeting of the Diabetes in Pregnancy Study Group of North America (DPSG-NA). J Matern Fetal Med 2000; 9 (1) 3-9
• 9 Langer O, Maulik D. Developing evidence-based medicine for managing diabetes in pregnancy. J Matern Fetal Neonatal Med 2002; 11 (4) 217
• 10 Obesity, diabetes and pregnancy. J Matern Fetal Neonatal Med 2008; 21 (3) 141
• 11 Reece EA, Homko C, Miodovnik M, Langer O. A consensus report of the Diabetes in Pregnancy Study Group of North America Conference, Little Rock, Arkansas, May 2002. J Matern Fetal Neonatal Med 2002; 12 (6) 362-364
• 12 Reece EA. Synopsis of the North American Diabetes in Pregnancy Study Group Conference in Little Rock, Arkansas, May 2003. J Matern Fetal Neonatal Med 2004; 15 (1) 1-5
• 13 Driggers RW, Baschat A. The 12th meeting of the Diabetes in Pregnancy Study Group of North America (DPSG-NA): introduction and overview. J Matern Fetal Neonatal Med 2012; 25 (1) 3-4